Optipharm KRX:153710KOSDAQ

옵티팜 · Korean news coverage and regulatory filings, organized.

Articles, 24h4
Articles, 7 days4
DART filings, 7 days2
Articles tracked11since Sep 11

In Q3 2026, Optipharm reported revenue of ₩6.5bn, up 13.9% year on year, and operating profit of ₩182m. Optipharm (옵티팜) appeared in 4 Korean news articles and 2 DART filings over the past seven days. Coverage peaked on Nov 16 with 4 articles. The most common catalyst was earnings (3).

Filing signals Turnaround Insider buying Screener

Optipharm at a glance from DART filings

Results trend
Operating profit in 1 of the last 4 quarters; Q3 2026 operating profit of ₩182m swung to a profit from a loss in the previous quarter.
Ownership changes
2 5%-holder and insider ownership reports in the past 120 days (2 increases, 0 decreases).

Figures the company filed on DART, grouped by ATS View. Not a buy or sell call; see the cards below and the DART originals.

Optipharm today: up or down?

No sign-up, one tap a day. These numbers show what visitors think and are not investment advice.

Upcoming dates as filed

  • Mar 31 Annual report filing deadlinein 134 days · period ending Dec 2026

Dates Optipharm stated in its DART filings. A conversion period opening does not mean new shares appear that day; bondholders must request conversion.

Optipharm quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q3 2026₩6.5bn+13.9%₩182m
margin 2.8%
₩164m
Q2 2026₩6.6bn+13.8%−₩206m
margin −3.1%
−₩217m
Q1 2026₩5.4bn+9.0%−₩723m
margin −13.5%
−₩754m
Q4 2025 derived₩6.0bn+6.5%−₩321m
margin −5.4%
−₩343m
Q3 2025₩5.7bn+18.6%−₩525m
margin −9.2%
−₩547m
Q2 2025₩5.8bn+16.9%−₩434m
margin −7.5%
−₩470m
Q1 2025₩4.9bn+14.4%−₩1.1bn
margin −23.1%
−₩1.1bn
Q4 2024 derived₩5.6bn+10.9%−₩251m
margin −4.5%
−₩229m

Optipharm ranks #1332 of 2,345 Korean listed companies by Q3 2026 operating profit. Q3 2026 Korean earnings rankings →

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Optipharm top stories 2 weeks, by number of outlets

  1. 1
    Optipharm Q3 operating profit and net income turn positive
    1 outlets · 1 articlesFirst report Nov 16 16:30 이코노미스트Earnings
  2. 2
    Optipharm returns to profitability in Q3... "second time since listing"
    1 outlets · 1 articlesFirst report Nov 16 16:29 뉴시스경제Earnings
  3. 3
    Optipharma achieves Q3 turnaround to profitability...second quarterly profit since listing
    1 outlets · 1 articlesFirst report Nov 16 17:04 EBNEarnings
  4. 4
    OptiFarm posts 646.7 million won in third-quarter revenue
    1 outlets · 1 articlesFirst report Nov 16 20:28 충청타임즈

Latest Optipharm news Korean headlines